The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,284
Sort by:
Global Crohn’s Disease Market - 2025-2033
US$ 2,999.00
The Global Crohn’s Disease Market was valued at USD 14.6 billion in 2025 and is anticipated to reach USD 21.8 billion by 2033, at a CAGR of 0.065 from 2026 to 2032. The report delivers in-depth insigh...
April 2026
220 pages
Myasthenia Gravis Therapeutics Market - 2025-2033
US$ 2,999.00
The Myasthenia Gravis Therapeutics Market was valued at USD 1.64 billion in 2025 and is anticipated to reach USD 3.48 billion by 2033, at a CAGR of 0.096 from 2026 to 2032. The report delivers in-dept...
April 2026
243 pages
Palmar Fibromatosis Market - 2025-2033
US$ 2,999.00
The Palmar Fibromatosis Market was valued at US$ 4.58 billion in 2025 and is anticipated to reach US$ 6.65 billion by 2033, at a CAGR of 0.048 from 2026 to 2032. The report delivers in-depth insights...
April 2026
217 pages